June marks important transition for brand-name drugs

Pharmacists United for Truth and Transparency Vice Chair Jason Wallace’s featured blog on Benefitspro.com tells HR Managers what to expect from PBMs as big revenue drugs move from brand to generic.

For years, Plavix and Lipitor, two of the most lucrative prescription medications in the history of the American drug market, have constituted quite a one-two punch.  Now, as Plavix loses its patent protection and Lipitor faces competition from multi-source generics, it’s an important time for consumers and benefits managers to understand how the transition from brand to generic will affect drug prices going forward. Read More….